RxDoctor Payments DataLook up a doctor →

James Chamberlain, MD

Internal Medicine · Salt Lake City, UTNPI 1093805681

Payments from drug & device makers

$106,389in general payments, 2019–2025

Across 646 payments — averaging $164.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Dexcom, Inc.$35K
  • Abbott$22K
  • Novo Nordisk$14K
  • Johnson & Johnson$12K
  • Tandem Diabetes Care, Inc.$12K
  • Sanofi-aventis U.S. LLC$2K
  • plus $9K from 37 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Dexcom, Inc.97$35,062
Abbott76$22,379
Novo Nordisk40$13,563
Johnson & Johnson(2 entities)18$12,492
Tandem Diabetes Care, Inc.37$11,999
Sanofi-aventis U.S. LLC53$2,176
Medtronic(2 entities)23$1,789
Lilly USA, LLC61$1,570
Boehringer Ingelheim42$758
Insulet Corporation10$657
BETA Bionics, Inc.14$617
Merck45$598
Ascensia Diabetes Care US Inc.6$463
Corcept Therapeutics12$354
Xeris Pharmaceuticals, Inc.11$223
Amgen12$172
Lifescan, Inc.11$155
AstraZeneca11$155
Novartis8$151
Insmed, Inc.9$138
Bayer8$137
Sequel Med Tech, LLC2$103
AbbVie4$69
Mannkind Corporation4$64
Amarin Pharma, Inc.4$58
Cequr Corporation2$50
Gilead2$49
Pfizer3$48
Paratek Pharmaceuticals, Inc.3$44
Lucid Diagnostics Inc.3$43
Cumberland Pharmaceuticals, Inc.2$28
Tetraphase Pharmaceuticals, Inc.1$26
Edwards Lifesciences1$24
Boston Scientific2$24
Actelion Pharmaceuticals US, Inc.1$20
Kyowa Kirin, Inc.1$19
Amphastar Pharmaceuticals, Inc.1$19
Biohaven Pharmaceuticals, Inc.1$19
Kowa Pharmaceuticals America, Inc.1$17
Inspire Medical Systems, Inc.1$15
Shionogi Inc1$15
Sanofi Pasteur Inc.1$14
BD1$13

How this compares

$106,389 in reported general payments places this provider in the 95th percentile of 496 internal medicine providers in Utah.

See all internal medicine providers in Utah →

Medicare billing

Part B allowed, 2024
$162,913
Medicare patients
224
Services billed
2,084

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Salt Lake City

See the full list for Utah →

Where these figures come from

Is this you, or does something look wrong? →